Core Scientific (CORZ) Expected to Release Quarterly Earnings on Friday

Key Points

• Core Scientific is expected to report Q2 2026 results before market open on Friday, August 14. Analysts project a loss of $0.02 per share and revenue of approximately $144.9 million.
• In its previous quarter, the company reported a much larger-than-expected loss of $3.32 per share, although revenue of $164.2 million exceeded estimates.
• Analysts maintain a generally positive view, with a “Moderate Buy” consensus and an average price target of $32.18; however, insiders sold 90,000 shares worth approximately $2.25 million during the last quarter.

Core Scientific (NASDAQ:CORZ - Get Free Report) is expected to post its Q2 2026 results before the market opens on Friday, August 14th. Analysts expect Core Scientific to post earnings of ($0.02) per share and revenue of $144.8990 million for the quarter. Interested persons are encouraged to explore the company's upcoming Q2 2026 earning report for the latest details on the call scheduled for Tuesday, July 28, 2026 at 8:30 AM ET.

Core Scientific (NASDAQ:CORZ - Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The company reported ($3.32) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by ($3.26). The company had revenue of $164.20 million during the quarter, compared to analyst estimates of $144.83 million. On average, analysts expect Core Scientific to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Core Scientific Stock Performance

CORZ stock opened at $21.05 on Friday. The stock has a market capitalization of $6.76 billion, a P/E ratio of -4.76 and a beta of 5.59. Core Scientific has a one year low of $13.14 and a one year high of $30.46. The company has a 50 day moving average price of $24.71 and a two-hundred day moving average price of $20.95.

Analyst Ratings Changes

Several equities research analysts recently issued reports on CORZ shares. Canaccord Genuity Group raised their target price on shares of Core Scientific from $30.00 to $36.00 and gave the stock a "buy" rating in a research report on Wednesday, July 29th. Cantor Fitzgerald boosted their price target on Core Scientific from $25.00 to $29.00 and gave the stock an "overweight" rating in a research note on Thursday, April 9th. Capital One Financial set a $33.00 price objective on Core Scientific in a research note on Thursday, July 30th. Keefe, Bruyette & Woods raised Core Scientific from a "market perform" rating to an "outperform" rating and upped their target price for the company from $25.00 to $28.00 in a research report on Thursday, July 30th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Core Scientific in a research report on Friday, July 17th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $32.18.

Insider Transactions at Core Scientific

In other news, insider Todd M. Duchene sold 10,000 shares of Core Scientific stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $22.23, for a total value of $222,300.00. Following the completion of the transaction, the insider directly owned 1,979,101 shares of the company's stock, valued at approximately $43,995,415.23. The trade was a 0.50% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders sold 90,000 shares of company stock worth $2,248,600 in the last quarter. Company insiders own 1.70% of the company's stock.

Hedge Funds Weigh In On Core Scientific

Institutional investors have recently modified their holdings of the company. Allworth Financial LP increased its stake in Core Scientific by 206.5% during the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company's stock valued at $25,000 after buying an additional 950 shares during the period. Osaic Holdings Inc. boosted its holdings in shares of Core Scientific by 112.1% in the second quarter. Osaic Holdings Inc. now owns 2,017 shares of the company's stock valued at $34,000 after acquiring an additional 1,066 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Core Scientific by 61.9% in the second quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company's stock valued at $67,000 after acquiring an additional 1,507 shares in the last quarter. State of Wyoming acquired a new position in shares of Core Scientific during the fourth quarter valued at approximately $66,000. Finally, Wilmington Savings Fund Society FSB acquired a new position in shares of Core Scientific during the third quarter valued at approximately $90,000.

Core Scientific Company Profile

Core Scientific, Inc NASDAQ: CORZ is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific's service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source